(Q44008835)

28 November 2017

title

Effect of surface charge and ligand organization on the specific cell-uptake of uPAR-targeted nanoparticles (English)

1 reference

28 November 2017

Ming Wang

1

1 reference

28 November 2017

Andrew D Miller

series ordinal

2

1 reference

28 November 2017

Maya Thanou

series ordinal

3

1 reference

28 November 2017

publication date

18 June 2013

1 reference

Journal of Drug Targeting

28 November 2017

published in

1 reference

28 November 2017

volume

21

1 reference

28 November 2017

issue

7

1 reference

28 November 2017

page(s)

684-692

1 reference

Active targeting schemes for nanoparticle systems in cancer therapeutics

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.805336

Factors affecting the clearance and biodistribution of polymeric nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.805336

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.805336

Exploiting the enhanced permeability and retention effect for tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.805336

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.805336

Targeting the urokinase plasminogen activator receptor with synthetic self-assembly nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.805336

Structure of human urokinase plasminogen activator in complex with its receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.805336

Mapping part of the functional epitope for ligand binding on the receptor for urokinase-type plasminogen activator by site-directed mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.805336

Structural analysis of the interaction between urokinase-type plasminogen activator and its receptor: a potential target for anti-invasive cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.805336

Solution structure of the amino-terminal fragment of urokinase-type plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.805336

Receptor-mediated endocytosis of plasminogen activators and activator/inhibitor complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.805336

Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.805336

The urokinase receptor (uPAR) and the uPAR-associated protein (uPARAP/Endo180): membrane proteins engaged in matrix turnover during tissue remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.805336

Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.805336

The plasminogen activation system in tumor growth, invasion, and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.805336

Modulators of the urokinase-type plasminogen activation system for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.805336

The urokinase-type plasminogen activator and the generation of inhibitors of urokinase activity and signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.805336

DODAG; a versatile new cationic lipid that mediates efficient delivery of pDNA and siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.805336

The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.805336

Inhibition of protein kinase C by cationic amphiphiles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.805336

Improved DNA: liposome complexes for increased systemic delivery and gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.805336

Structure and gene silencing activities of monovalent and pentavalent cationic lipid vectors complexed with siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.805336

DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.805336

Increased target specificity of anti-HER2 genospheres by modification of surface charge and degree of PEGylation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.805336

Membrane-active properties of alpha-MSH analogs: aggregation and fusion of liposomes triggered by surface-conjugated peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.805336

The architecture of ligand attachment to nanocarriers controls their specific interaction with target cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.805336

Recognition and clearance of methoxypoly(ethyleneglycol)2000-grafted liposomes by macrophages with enhanced phagocytic capacity. Implications in experimental and clinical oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.805336

The complement system in liposome clearance: Can complement deposition be inhibited?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.805336

Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.805336

Biophysical Characterization of an Integrin-Targeted Lipopolyplex Gene Delivery Vector†

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2013.805336

10.3109/1061186X.2013.805336

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference